ELIGARD (leuprolide acetate) is indicated for the palliative due to incorrect reconstitution or administration of the product (see Monitoring and Laboratory .. Gently insert the long, white replacement plunger rod into the gray. PACKAGE LEAFLET: INFORMATION FOR THE USER. ELIGARD 45 mg powder and solvent for solution for injection. Leuprorelin acetate. Read all of this leaflet. Eligard® is a sterile polymeric matrix formulation of leuprorelin acetate for subcutaneous package insert for constitution and administration procedures.

Author: Arashijar Faukinos
Country: Mozambique
Language: English (Spanish)
Genre: Travel
Published (Last): 11 July 2018
Pages: 73
PDF File Size: 7.74 Mb
ePub File Size: 12.5 Mb
ISBN: 265-5-37316-375-5
Downloads: 47459
Price: Free* [*Free Regsitration Required]
Uploader: Mazugami

Major Concomitant use of ziprasidone and packxge should be avoided due to the potential for additive QT prolongation.

Use these drugs together cautiously and with pacckage monitoring. Drugs such as ganirelix and cetrorelix are now more commonly used and are FDA-approved for this purpose.

In clinical trials, QT prolongation has been reported in patients who received midostaurin as single-agent therapy or in combination with cytarabine and daunorubicin.

Because the condition is reversible if the drug is discontinued, therapy must be continuous.

Because of the potential for TdP, use of. Moderate Use gemtuzumab ozogamicin and leuprolide together with caution due to the potential for additive QT interval prolongation and risk of torsade de pointes TdP. Additionally, some antipsychotics may induce hyperprolactinemia, resulting in down-regulation of the number of pituitary GnRH receptors and may eligar with the response to leuprolide therapy.

QT prolongation should be expected with the administration of arsenic trioxide. In the male, this activity stops testosterone production in the testis. Leuprolide therapy interrupts menstruation; women who continue to isnert or who experience breakthrough bleeding while receiving leuprolide should notify their physician.

Clinically relevant QTc prolongation may occur with deutetrabenazine. If these agents are used together, obtain an ECG and serum electrolytes prior to the start of gemtuzumab and as needed during treatment. Patients who are allergic to benzyl alcohol may have an allergic reaction.


Take care to verify the correct product and intent of use prior to administration.

Manage patients according to current clinical practice. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously and with close monitoring with leuprolide include fingolimod.

Chlorpromazine is specifically associated with an established risk of QT prolongation and TdP ; case reports have included patients receiving therapeutic doses of chlorpromazine. The product must be mixed as described; shaking the product will not provide adequate mixing of the product. Administer as a single dose subcutaneously.

Inotuzumab has been associated with QT interval prolongation. Quinidine is associated with QT prolongation and torsades de pointes TdP. The QT prolongation appeared less with alfuzosin 10 mg than with 40 mg. Depot IM injection Administration: For patients who are self-administering leuprolide injection, make sure they are using the syringes provided by the manufacturer.

Eligard (leuprolide acetate) dose, indications, adverse effects, interactions from

Efavirenz; Lamivudine; Tenofovir Disoproxil Fumarate: Major Halogenated anesthetics are associated with a risk for QT prolongation and potential cardiac arrhythmias. Moderate Loperamide should be used cautiously and with close monitoring with leuprolide. Also use with caution in patients with cardiac disease or other conditions that may increase the risk of QT prolongation including cardiac arrhythmias, bradycardia, myocardial infarction, inser, coronary artery disease, or in patients receiving medications known to prolong the QT interval or cause electrolyte imbalances.

Recipient’s Fligard Separate multiple email address with a comma Please enter valid email address Recipient’s email is required. During postmarketing experience, emotional lability, such as crying, irritability, impatience, anger, and aggression were reported.

Drugs with a possible risk for QT prolongation and torsade de pointes TdP that should be used cautiously and with close monitoring with bedaquiline include leuprolide.

Moderate There may be an increased risk for QT prolongation and torsade de pointes TdP insegt concurrent use of mirtazapine and leuprolide. This risk is generally higher at elevated drugs concentrations of phenothiazines.

Quetiapine is associated with a possible risk for QT prolongation and TdP and should be used cautiously and with close monitoring with leuprolide. If it is absolutely necessary to use a different syringe, only a 0. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously with posaconazole include leuprolide.


The Viadur implant and Eligard brands paciage leuprolide are contraindicated in females due to due to a lack ellgard indication for use and limited experience, thus these products would not be given to the lactating female. Leuprolide has been designated an orphan drug by the FDA for this indication. LHRH-analogs aka GnRH analogs have been used alone or added to growth hormone rh-GH therapy to moderately increase adult height in adolescents with normally timed puberty and idiopathic short packagge the LHRH-analogs delay puberty and thus prolong the period of bone growth via delay of sex hormone-induced growth-plate senescence.

Uncouple syringe A while continuing to push down on the syringe A plunger.

Halogenated anesthetics should be used cautiously and with close monitoring in patients receiving leuprolide. For all Depot-Ped formulations: Seizures have been reported during postmarketing surveillance in patients with a history of epilepsy, cerebrovascular disease, central nervous system anomalies or brain tumor, and patients on concomitant medications that have been associated with seizures.

At this time, there are no known comparable studies evaluating the risk of diabetes in women or children taking GnRH agonists for other indications. The recommended dose is 15 mg IM as a single dose eoigard every 4 weeks.

Seizures have also been reported in patients without any risk factors.

PDR Search

Consider ECGs and close clinical monitoring if co-use of such drugs is medically necessary. Promethazine a phenothiazine antiemetic and antihistamine carries a possible risk of QT prolongation. Additionally, even though patients experience a decrease in libido, most are able to engage in sexual activity.

This article was written by admin